Waters Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Waters Corporation (WAT)
Waters Corporation stock price live, this page displays NYSE WAT stock exchange data. View the WAT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Waters Corporation real time stock price chart below.
What Is the Waters Corporation Stock Price Today?
The Waters Corporation stock price today is 323.37.
What Is the Stock Symbol for Waters Corporation?
The stock symbol for Waters Corporation is "WAT."
What Stock Exchange Does Waters Corporation Trade On?
Waters Corporation is listed and trades on the NYSE stock exchange.
Is Waters Corporation a Good Stock to Buy?
Determining whether Waters Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WAT quote. (ISIN: US9418481035)
What Is the Waters Corporation Stock Price Today?
The Waters Corporation stock price today is 323.37.
What Is the Stock Symbol for Waters Corporation?
The stock symbol for Waters Corporation is "WAT."
What Stock Exchange Does Waters Corporation Trade On?
Waters Corporation is listed and trades on the NYSE stock exchange.
Is Waters Corporation a Good Stock to Buy?
Determining whether Waters Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WAT quote. (ISIN: US9418481035)
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
314.09
325.87
52 wk Range
275.05
414.15
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
314.09325.87
52 wk Range
275.05414.15
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
WAT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
402.71
Upside
+24.54%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Waters Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Waters Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Waters Corporation Company Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, and other consumable products. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Waters Corporation SWOT Analysis
Biologics Boost | Waters Corporation strategically positions itself in the rapidly expanding biologics market, with acquisitions and product developments strengthening its offerings in this high-growth sector. |
Financial Health | Explore Waters' robust financial metrics, including a 59.3% gross profit margin and nearly $3 billion in annual revenue, underpinning its strategic initiatives and market expansion. |
Market Dynamics | Delve into the projected 10.3% CAGR of the biologics market through 2028, and how Waters' specialized expertise in QA/QC for biopharmaceuticals positions it for potential outperformance. |
Analyst Outlook | Analyst price targets range from $360 to $460, reflecting varied perspectives on Waters' growth potential amid its focus on high-growth areas like GLP-1 treatments and biologics. |
Waters Corporation Earnings Call Summary for Q4/2025
- Waters Corp. reported Q4 2025 adjusted EPS of $4.53 (beating $4.51 forecast) and revenue of $932M (exceeding $928.09M expectations), yet stock fell 14.49% to $326.04 pre-market.
- Revenue grew 7% year-over-year with strong performance from Alliance iS HPLC and Xevo TQ Absolute platforms; full-year adjusted EPS rose 11% to $13.13.
- The company completed a significant acquisition of BD's Biosciences and Diagnostic Solutions, which is expected to contribute $3B in revenue.
- For 2026, Waters projects organic constant currency revenue growth of 5.5-7%, with total revenue guidance of $6.405-6.455B and adjusted EPS of $14.30-14.50.
- CEO Udit Batra described the BD integration as creating 'a scientific powerhouse' and characterized the 5.3% midpoint growth outlook as 'appropriately prudent, yet industry-leading.'
Last Updated: 2026/02/09, 16:56
Read Full TranscriptCompare WAT to Peers and Sector
Metrics to compare | WAT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWATPeersSector | |
|---|---|---|---|---|
P/E Ratio | 49.4x | 21.5x | −0.5x | |
PEG Ratio | 63.47 | 0.78 | 0.00 | |
Price/Book | 12.4x | 3.7x | 2.6x | |
Price / LTM Sales | 10.0x | 2.2x | 3.3x | |
Upside (Analyst Target) | 25.1% | 47.4% | 47.0% | |
Fair Value Upside | Unlock | 11.0% | 6.1% | Unlock |
Analyst Ratings
11 Buy
12 Hold
0 Sell
Ratings:
23 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 402.71
(+24.54% Upside)
Earnings
Latest Release
Feb 09, 2026
EPS / Forecast
4.53 / 4.51
Revenue / Forecast
932.00M / 928.09M
FAQ
What Is the Waters (WAT) Stock Price Today?
The Waters stock price today is 323,37
What Stock Exchange Does Waters Trade On?
Waters is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Waters?
The stock symbol for Waters is "WAT."
What Is the Waters Market Cap?
As of today, Waters market cap is 31,72B.
What Is Waters's Earnings Per Share (TTM)?
The Waters EPS (TTM) is 10.76.
When Is the Next Waters Earnings Date?
Waters will release its next earnings report on May 12, 2026.
From a Technical Analysis Perspective, Is WAT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Waters Stock Split?
Waters has split 2 times.
How Many Employees Does Waters Have?
Waters has 7900 employees.
What is the current trading status of Waters (WAT)?
As of 14 Feb 2026, Waters (WAT) is trading at a price of 323,37, with a previous close of 319,83. The stock has fluctuated within a day range of 314,09 to 325,87, while its 52-week range spans from 275,05 to 414,15.
What Is Waters (WAT) Price Target According to Analysts?
The average 12-month price target for Waters is USD402,71, with a high estimate of USD480 and a low estimate of USD330. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +24,54% Upside potential.
What Is the WAT Premarket Price?
WAT's last pre-market stock price is 315,70. The pre-market share volume is 930,00, and the stock has decreased by -4,13, or -1,29%.
What Is the WAT After Hours Price?
WAT's last after hours stock price is 321,14, the stock has decreased by -2,23, or -0,69%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.